November 2, 2018

End Duchenne Tour Recap: Dallas, TX

PPMD was thrilled to head south to Dallas Texas for our October End Duchenne Tour stop on October 13, 2018. More than 80 people came together to learn about the latest information and resources for Duchenne…

Learn More

November 1, 2018

PPMD Designates Children’s National Health System a Certified Duchenne Care Center

Today Parent Project Muscular Dystrophy (PPMD) named Children’s National Health System our 20th Certified Duchenne Care Center. PPMD’s Certified Duchenne Care Center Program, which supports standardized, comprehensive care and services for all people living with Duchenne, began…

Learn More

October 31, 2018

WATCH: An Update on Corticosteroids – Webinar Recording

PPMD and Dr. John Brandsema hosted a webinar on October 24, 2018 to discuss the current guidelines for steroid use in Duchenne muscular dystrophy, emerging data, and best practices. If you missed the live event,…

Learn More

October 25, 2018

Behavior Challenges and Duchenne: Part 3 – Resources

Psychosocial health (also called “mental health”) includes behavior, emotional adjustment, learning/school success, and relationships. These things are very important for overall well-being and quality of life. Addressing the psychosocial needs of a person with Duchenne is…

Learn More

October 16, 2018

Behavior Challenges and Duchenne: Part 2 – Establishing Consequences

Psychosocial health (also called “mental health”) includes behavior, emotional adjustment, learning/school success, and relationships. These things are very important for overall well-being and quality of life. Addressing the psychosocial needs of a person with Duchenne is…

Learn More

October 15, 2018

WATCH: Is Myostatin Still a Potential Therapeutic Target? – Webinar Recording

Myostatin is a negative regulator of muscle growth – a protein that stops muscle building and doesn’t let them get too big, as part of the natural regeneration process. In other words, if we can…

Learn More

October 11, 2018

Pediatrics Supplement Focuses on Specialty Care for People with Duchenne

The supplement “Specialty Care for the Patient with Duchenne Muscular Dystrophy” was recently published in the October 2018 issue of Pediatrics. The supplement aims to raise the standard of care and improve quality of life…

Learn More

October 9, 2018

2018 World Muscle Society Update

Last week, PPMD’s Founding President and CEO, Pat Furlong and our SVP of Research Strategy, Abby Bronson attended the annual World Muscle Society (WMS) meeting, this year in Mendoza, Argentina. Pat and Abby have provided…

Learn More

October 5, 2018

NS Pharma Announces Positive Results of US/Canada Phase II Clinical Trial of Viltolarsen at World Muscle Society

NS Pharma announced positive results of a US/Canada Phase II clinical trial of viltolarsen at the World Muscle Society meeting held in Mendoza, Argentina. The preliminary findings suggest clinical improvement as measured by timed function…

Learn More

October 4, 2018

Jerry Mendell, M.D. Shares Positive Updated Results from Gene Therapy Micro-dystrophin Trial

  PPMD is excited to learn that Dr. Jerry Mendell of Nationwide Children’s Hospital today shared positive results for the fourth patient in Sarepta’s micro-dystrophin trial, indicating positive functional signals for all of the patients….

Learn More